HKD 0.21
(-4.11%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 72.54 Billion CNY | -64.86% |
2022 | 206.44 Billion CNY | -7.73% |
2021 | 223.74 Billion CNY | 21.04% |
2020 | 184.84 Billion CNY | 74.49% |
2019 | 105.93 Billion CNY | 306.63% |
2018 | 26.05 Billion CNY | 217.94% |
2017 | 8.19 Billion CNY | 225.28% |
2016 | 2.51 Billion HKD | 797.64% |
2015 | 280.62 Million CNY | 31.5% |
2014 | 213.4 Million CNY | 373.37% |
2013 | 45.08 Million HKD | -11.28% |
2012 | 50.81 Million HKD | -52.69% |
2011 | 107.4 Million HKD | -11.44% |
2010 | 121.27 Million CNY | 53.59% |
2009 | 78.96 Million CNY | 15.56% |
2008 | 68.32 Million CNY | 4.7% |
2007 | 65.26 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 72.54 Billion CNY | -64.86% |
2023 Q2 | 75.69 Billion HKD | 0.0% |
2023 Q4 | 72.54 Billion CNY | 0.0% |
2022 Q2 | 216.22 Billion CNY | 0.0% |
2022 FY | 206.44 Billion CNY | -7.73% |
2022 Q4 | 183.87 Billion CNY | 0.0% |
2021 FY | 223.74 Billion CNY | 21.04% |
2021 Q4 | 182.9 Billion CNY | 0.0% |
2021 Q2 | 183.9 Billion CNY | 0.0% |
2020 FY | 184.84 Billion CNY | 74.49% |
2020 Q2 | 141.75 Billion CNY | 0.0% |
2020 Q4 | 184.84 Billion CNY | 0.0% |
2019 Q2 | 76.29 Billion CNY | 0.0% |
2019 Q4 | 105.93 Billion CNY | 0.0% |
2019 FY | 105.93 Billion CNY | 306.63% |
2018 FY | 26.05 Billion CNY | 217.94% |
2018 Q4 | 26.05 Billion CNY | 0.0% |
2018 Q2 | 10.76 Billion CNY | 0.0% |
2017 Q4 | 8.19 Billion CNY | 0.0% |
2017 Q2 | 4.47 Billion CNY | 0.0% |
2017 FY | 8.19 Billion CNY | 225.28% |
2016 Q4 | 2.51 Billion HKD | 0.0% |
2016 Q2 | 951.83 Million CNY | 0.0% |
2016 FY | 2.51 Billion HKD | 797.64% |
2015 Q2 | 56.59 Million CNY | 0.0% |
2015 Q4 | 235.09 Million CNY | 0.0% |
2015 FY | 280.62 Million CNY | 31.5% |
2014 Q4 | 45.25 Million CNY | 0.0% |
2014 FY | 213.4 Million CNY | 373.37% |
2014 Q2 | 56.17 Million CNY | 0.0% |
2013 Q1 | 60.8 Million HKD | -40.99% |
2013 FY | 45.08 Million HKD | -11.28% |
2013 Q4 | 55.16 Million HKD | -18.61% |
2013 Q3 | 67.77 Million HKD | 33.38% |
2013 Q2 | 50.81 Million HKD | -16.43% |
2012 Q1 | 128.08 Million HKD | 3.14% |
2012 FY | 50.81 Million HKD | -52.69% |
2012 Q2 | 107.4 Million HKD | -16.14% |
2012 Q3 | 125.51 Million HKD | 16.85% |
2012 Q4 | 103.03 Million HKD | -17.91% |
2011 Q2 | 121.27 Million CNY | 0.0% |
2011 Q4 | 124.18 Million CNY | 0.0% |
2011 FY | 107.4 Million HKD | -11.44% |
2010 Q2 | 78.96 Million CNY | 0.0% |
2010 FY | 121.27 Million CNY | 53.59% |
2010 Q4 | 71.35 Million CNY | 0.0% |
2009 FY | 78.96 Million CNY | 15.56% |
2008 FY | 68.32 Million CNY | 4.7% |
2007 FY | 65.26 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 1.2 Billion HKD | -5924.102% |
UMP Healthcare Holdings Limited | 362.14 Million HKD | -19931.567% |
Human Health Holdings Limited | 289.7 Million HKD | -24940.237% |
EuroEyes International Eye Clinic Limited | 588.09 Million HKD | -12235.411% |
Kato (Hong Kong) Holdings Limited | 428.77 Million HKD | -16818.777% |
Bamboos Health Care Holdings Limited | 99.73 Million HKD | -72635.34% |
Beijing Health (Holdings) Limited | 223.82 Million HKD | -32311.021% |
C-MER Eye Care Holdings Limited | 755.34 Million HKD | -9503.947% |
Town Health International Medical Group Limited | 881.82 Million HKD | -8126.545% |
Medicskin Holdings Limited | 32.47 Million HKD | -223254.534% |
Hang Chi Holdings Limited | 100.92 Million HKD | -71775.595% |